Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Zeitschrift Fur Rheumatologie|July 5, 2006
[Treatment of systemic sclerosis]F H J van den Hoogen
Annals of the Rheumatic Diseases|May 28, 2005
Disease related use of the internet in chronically ill adults: current and expected useW G J M van Lankveld, A M Derks, F H J van den Hoogen
Rheumatology (Oxford, England)|February 20, 2007
Appearance self-esteem in systemic sclerosis--subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variablesW G J M van Lankveld, M C Vonk, H Teunissen, et al.
Osteoarthritis and Cartilage|March 3, 2020
Effect of the dr. Bart application on healthcare use and clinical outcomes in people with osteoarthritis of the knee and/or hip in the Netherlands; a randomized controlled trialT Pelle, K Bevers, J van der Palen, et al.
Scandinavian Journal of Rheumatology|November 11, 2008
Regional migratory osteoporosis in a patient with ankylosing spondylitisV H H P Straten, M J A M Franssen, A A den Broeder, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Measurement characteristics of a new rapid anti-CCP2 test compared to the anti-CCP2 ELISAG F Snijders, A A den Broeder, K Bevers, et al.
Scandinavian Journal of Rheumatology|February 6, 2010
Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stressH Hargardóttir, H A C van Helvoort, M C Vonk, et al.
Annals of the Rheumatic Diseases|November 5, 2005
Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practiceA A den Broeder, E de Jong, M J A M Franssen, et al.
The British Journal of Dermatology|February 13, 2009
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort studyE B M Kroft, M C W Creemers, F H J van den Hoogen, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritisT R D J Radstake, M Svenson, A M Eijsbouts, et al.
Pageof 4